Search

Your search keyword '"Emile Voest"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Emile Voest" Remove constraint Author: "Emile Voest"
31 results on '"Emile Voest"'

Search Results

1. Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

2. The Porto European Cancer Research Summit 2021

3. Towards a cancer mission in Horizon Europe: recommendations

4. Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

5. Cancer Core Europe: A translational research infrastructure for a European mission on cancer

8. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity

9. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

11. Phase <scp>II</scp> study ( <scp>KAMELEON</scp> ) of single‐agent <scp>T‐DM1</scp> in patients with <scp>HER2</scp> ‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

12. Supplementary Figure 1 from Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

13. Supplementary table 1 from Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

14. Supplementary table 3 from Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

15. Data from Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

16. Supplementary table 2 from Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

17. Base editing screens map mutations affecting IFNγ signalling in cancer

18. Abstract A50: IFNλ1 is a marker of DNA damage-triggered STING-signaling in lung cancer that induces immune activation through macrophage stimulation

19. Delivering precision oncology to patients with cancer

20. Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

21. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

22. TANGO Project Mini Symposium 2018 - Presentations

23. Cancer genome: highlights of a

24. ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016

26. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens

27. A zebrafish model for VHL and hypoxia signaling

28. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

29. Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum.

30. MR Imaging of Mouse Leptomeningeal Metastases.

31. American Society of Clinical Oncology Statement: Biosimilars in Oncology.

Catalog

Books, media, physical & digital resources